We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
VanV - I take my hat off to you; a well articulated post, which hit the nail on the head. Carpe diem, Novacyt!
Exactly Balanced IAG is key to to the bleating. K
Triumph - so there's an admission there from you that at the moment it's not good enough for airports etc and needs improving. So people were selling today because of these tests which are still in very early development? Erm I don't think so. It's a period of consolidation imv. If people were selling because of these potential new tests then we would have expected there to be buying of those shares that could benefit from these new tests. That didn't happen though did it? I see IAG ended down - one of your shares I believe so according to you it should have gone up as these new breath tests would open up flights again once they are improved to 95%.
Actually it’s NOT proven as the sample set is too small, it needs financial backing and the point really is that it’s not available today and it’s still in development.
So let’s not get excited about what may or may not be coming next, for all you know NCYT could be working on a similar product, who knows.
Well its good you can all be so confident as to dismiss the results as "crap". Laughable really. From July to now is not exactly slow. Imspex have some good backing including the NHS trust, and after this have put the tech potential firmly on the radar as a challenger to the PCR. The accuracy could increase significantly with more data, and investors will be quite literally throwing money at them hands over fist. This news would have certainly garnered some interest, no doubt about that as an 80% success rate for a very limited trial is a very good start!
So, Shaun. Should NCYT holders be concerned? lets put it this way, it would be rather foolish to dismiss this tech as "clickbait" and completely disregard it. Many countries worked on a PCR and still are, NCYT got the breakthrough and the best test to date. Many are working on a breath test, and with an 80% success rate in a very limited first trial shows it could have legs whether it be by imspex or someone else. Funding and scaling will happen at breakneck speed if it was as simple as blowing into a tube and get a result in 1 min. 95% accuracy would be good enough in airports purely for the simplicity and practicality. A 98%+ test would be truly revolutionary and render the PCR as virtually obsolete. So i think your answer of whether investors should be concerned is a little more complicated than "no", and any prudent investor would never dismiss such news. Judging by the selloff today, many didn't dismiss.
Besides, is it not good news that a new tech could potentially save lives? Anyone would think the way some are talking on here is that a groundbreaking new test would be a disaster.....
Pete7,i am thick skinned mate,no grudges.
Firex ....Thankyou for posting that....to all those there a 1 million buy.....that's not confidence....that's someone in the know, that is not punt money....
Someone is confident.
Oct-2016:56: 401,007.65422106,293 Buy*1m
80% Accuracy,as much use as an ash tray on a motorbike,just hold for gold,GM will start to release some stonking news within the next 2 weeks imho,GLA.
Have to admit 80% is probably bordering on legal action. If someone got ill after being advised they were all clear, infects multiple people / family member dies. The only use I can think of is where people already get tested regularly, the test is run at the front of an event... can you process 800 people in 20 mins? Who knows what Novacyt has up their sleeve. They have been consistently plonking new products on the table before the Government thinks, 'We need one of those'.
Nah I'll stick here thanks.
a) It still in dev and a long way off
b) it’s not proven
c) what if you are not showing any signs?
If you want to test the entire U.K.and track and trace the fastest way imo would be to send every household a saliva based test kit and request they post it back. This is what I expect will be more likely?
80% accuracy...Lol
1 Million after hours BUY just printed
That's it then... I guess we should all sell tomorrow. :-)
The breath tests with 80% accuracy will be dismissed as misleading and a waste of time - years from fruition imv.
I think the drop was orchestrated by people trying to cause panic selling by inexperienced PI's maybe with the dm article as the catalyst. Expecting recovery by Friday - we shall see.
Triumph, you're right. Worst case scenario is that novacyt's products fall out of favour and the company is left with around £300m cash to go in new directions (making the current mcap of £700m still fairly low).
The best case scenario is novacyt's instruments are embedded across the nhs with rolling government contracts into the long term - making the current mcap of £700m an absolute steal).
My money is staying put.
https://www.dailymail.co.uk/sciencetech/article-8884855/Breath-test-diagnose-Covid-19-one-minute.html
This industry is moving at a rapid pace. Looks like many viable solutions could replace PCR....